Characterization of the increase in [Ca(2+)](i) during hypotonic shock and the involvement of Ca(2+)-activated K(+) channels in the regulatory volume decrease in human osteoblast-like cells.
The calcium indicator fura-2 was used to study the effect of hypotonic solutions on the intracellular calcium concentration, [Ca(2+)](i), in a human osteoblast-like cell line. Decreasing the tonicity of the extracellular solution to 50% leads to an increase in [Ca(2+)](i) from approximately 150 nm up to 1.3 microm. This increase in [Ca(2+)](i) was mainly due to an influx of extracellular Ca(2+) since removing of extracellular Ca(2+) reduced this increase to approximately 250 nm. After cell swelling most of the cells were able to regulate their volume to the initial level within 800 sec. The whole-cell recording mode of the patch-clamp technique was also used to study the effect of an increase in [Ca(2+)](i) on membrane currents in these cells. An increase in [Ca(2+)](i) revealed two types of Ca(2+)-activated K(+) channels, K(Ca) channels. Current through both channel types could not be observed below voltage of +80 mV with [Ca(2+)](i) buffered to 100 nm or less. With patch-electrodes filled with solutions buffering [Ca(2+)](i) to 10 microm both channels types could be readily observed. The activation of the first type was apparently voltage-independent since current could be observed over the entire voltage range used from -160 to +100 mV. In addition, the current was also blocked by charybdotoxin (CTX). The second type of K(Ca) channels in these cells could be activated with depolarizations more positive than -40 mV from a holding potential of -80 mV. This type was blocked by CTX and paxilline. Adding paxilline to the extracellular solution inhibited regulatory volume decrease (RVD), but could not abolish RVD. We conclude that two K(Ca) channel types exist in human osteoblasts, an intermediate conductance K(Ca) channel and a MaxiK-like K(Ca) channel. MaxiK channels might get activated either directly or by an increase in [Ca(2+)](i) elicited through hypotonic solutions. In combination with the volume-regulated Cl(-) conductance in the same cells this K(+) channel seems to play a vital role in volume regulation in human osteoblasts.
Weskamp
M
M
Department of Applied Physiology, University Ulm, 89081 Ulm, Germany.
Seidl
W
W
Grissmer
S
S
D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D018999:Charybdotoxin / Q000494:pharmacology; D004594:Electrophysiology; D006801:Humans; D007038:Hypotonic Solutions; D007211:Indoles / Q000494:pharmacology; D051660:Intermediate-Conductance Calcium-Activated Potassium Channels; D051037:Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; D051036:Large-Conductance Calcium-Activated Potassium Channels; D010006:Osteoblasts / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D026902:Potassium Channel Blockers; D015221:Potassium Channels / Q000502:physiology*; D024681:Potassium Channels, Calcium-Activated
D007038:Hypotonic Solutions; D007211:Indoles; D051660:Intermediate-Conductance Calcium-Activated Potassium Channels; C494841:KCNMA1 protein, human; C496923:KCNN4 protein, human; D051037:Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; D051036:Large-Conductance Calcium-Activated Potassium Channels; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D024681:Potassium Channels, Calcium-Activated; D018999:Charybdotoxin; C048220:paxilline; D002118:Calcium